The increasing interest in effective weight management has led to considerable research into groundbreaking treatments. Lately , Retatrutide, a dual -action GIP and glucagon-like peptide-1 (GLP-1) receptor agonist , has exhibited positive results in clinical trials, implying potential for substantial weight reduction . As a result , several individ